Contribution of Renal and Non‐Renal Clearance on Increased Total Clearance of Adalimumab in Glomerular Disease

Publisher: John Wiley & Sons Inc

E-ISSN: 1552-4604|53|9|919-924

ISSN: 0091-2700

Source: JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.53, Iss.9, 2013-09, pp. : 919-924

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content